EPHA2 and neoplasm: We detected no significant differences in tumor cell proliferation (Fig. 3A, graph, n.s. = not significant) or survival (Fig. 3B, graph, n.s. = not significant) in MDA.V versus MDA.A2KD tumors in bone, suggesting EphA2 loss of function does not affect tumor cell growth or survival in the bone microenvironment (Fig. 3A,B).